74.25 USD
↘ 0.21 (0.28%)LIVE (AS OF 01:08 PM EDT)
Tarsus Pharmaceuticals, Inc. Common Stock
TARSNASDAQ • USD
Market: OPEN
Tarsus Pharmaceuticals, Inc. Common Stock (TARS) trades at $74.25 per share. The technical outlook is "Neutral" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$74.48
High?$75.19
Low?$73.01
Prev. Close?$74.46
Volume?155.1K
Avg. Volume?823.4K
VWAP?$74.18
Rel. Volume?0.19x
Bid / Ask
Bid?$64.44 × 100
Ask?$85.78 × 100
Spread?$21.34
Midpoint?$75.11
Valuation & Ratios
Market Cap?3.5B
Shares Out?43.9M
Float?37.9M
Float %?86.3%
P/E Ratio?N/A
P/B Ratio?10.05
EPS?-$1.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Employees
370
Market Cap
3.5B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
15440 LAGUNA CANYON ROAD
IRVINE, CA 92618
Phone: (949) 409-9820
IRVINE, CA 92618
Phone: (949) 409-9820
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?94
Short Sent.?45
Piotroski F-Score?3/9Weak
Altman Z-Score?8.36Safe
Confidence?57%Low
Short InterestHigh
Short % of Float?16.17%High
Short Interest?6.1M
Days to Cover?6.6
Free Float37.9M
Avg Daily Volume923.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.20Strong
Quick Ratio?3.17Strong
Cash Ratio?1.16Strong
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score60/100
P/E?N/A▾
P/B?10.05HIGH▾
Peers100
S&P19
P/S?5.75FAIR▾
Peers100
S&P24
P/FCF?62.2PRICEY▾
Peers100
S&P7
EV/EBITDA?-64.9CHEAP▾
S&P97
EV/Sales?5.53FAIR▾
Peers100
S&P32
Returns & Efficiency
ROE?-13.5%WEAK▾
S&P9
ROA?-7.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$56.0M
Enterprise Value?$3.4B
Fundamentals ratios updated end of day